Available company data, source links and archived checks for Aurobindo Pharma Limited. Read each source and date: a past check is not a fresh review, and some earlier figures have incomplete source details.
Quarter ended 2026-06-30 · consolidated · Company filing
| Quarter | Revenue / income | YoY | Profit | YoY | Net margin | Source |
|---|---|---|---|---|---|---|
| Jun 2026 | Revenue: ₹9,150 cr | +16.3% | Net profit: ₹1,032 cr | +25.2% | 11.3% | Company filing source |
| Mar 2026 | Revenue: ₹8,853 cr | +5.6% | Net profit: ₹921 cr | +2.0% | 10.4% | Company filing source |
| Dec 2025 | Revenue: ₹8,646 cr | — | Net profit: ₹910 cr | — | 10.5% | Company filing source |
| Sep 2025 | Revenue: ₹8,286 cr | — | Net profit: ₹848 cr | — | 10.2% | Company filing source |
| Jun 2025 | Revenue: ₹7,868 cr | +4.0% | Net profit: ₹824 cr | -10.2% | 10.5% | Company filing source |
| Mar 2025 | Revenue: ₹8,382 cr | — | Net profit: ₹903 cr | — | 10.8% | Company filing source |
YoY means change from the same quarter a year earlier. — means no comparable figure is available. Older entries with incomplete source details have not been revalidated under the current checks.
A1 Biochem USA Inc is a newly incorporated entity, incorporated on August 27, 2026 in the USA, in the Pharmaceuticals industry.
A1 Biochem USA Inc is a wholly owned subsidiary of A1 Biochem Labs (India) Private Limited, which is a subsidiary of Apitoria Pharma Private Limited, itself a wholly owned subsidiary of the Company, and therefore the target is a related party of the Company.
A1 Biochem USA Inc is yet to commence business, so no turnover applies and no last-three-years turnover history is available.
A1 Biochem USA Inc's stated object is to undertake Contract Research and Development services business, as part of the previously disclosed acquisition of the A1 Biochem Group (disclosed July 23, 2026).
AUROPHARMA: consolidated net profit changed by 25.2% in the quarter ending 30 June 2026, compared with the quarter ending 2025-06-30.
Keep its available filings, dated fact checks and disclosure alerts together. Your saved country sets your market and its research schedule.
Start free — first week on us →Company data and archived claim checks are shown with available sources. Check the source and date before relying on a figure. This is not investment advice or a recommendation. Investment in securities markets is subject to market risks. Research on this site is produced with substantial use of AI. Terms, disclosures and grievances